- Home
- XRTX vs ALLR Comparison
XRTX vs ALLR Comparison
Compare XRTX & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- ALLR
- Stock Information
- Founded
- XRTX 2011
- ALLR 2004
- Country
- XRTX Canada
- ALLR United States
- Employees
- XRTX N/A
- ALLR N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- XRTX Health Care
- ALLR Health Care
- Exchange
- XRTX Nasdaq
- ALLR Nasdaq
- Market Cap
- XRTX 4.2M
- ALLR 4.0M
- IPO Year
- XRTX N/A
- ALLR N/A
- Fundamental
- Price
- XRTX $0.92
- ALLR $0.85
- Analyst Decision
- XRTX
- ALLR
- Analyst Count
- XRTX 0
- ALLR 0
- Target Price
- XRTX N/A
- ALLR N/A
- AVG Volume (30 Days)
- XRTX 34.6K
- ALLR 564.6K
- Earning Date
- XRTX 05-16-2025
- ALLR 08-04-2025
- Dividend Yield
- XRTX N/A
- ALLR N/A
- EPS Growth
- XRTX N/A
- ALLR N/A
- EPS
- XRTX N/A
- ALLR N/A
- Revenue
- XRTX N/A
- ALLR N/A
- Revenue This Year
- XRTX N/A
- ALLR N/A
- Revenue Next Year
- XRTX N/A
- ALLR N/A
- P/E Ratio
- XRTX N/A
- ALLR N/A
- Revenue Growth
- XRTX N/A
- ALLR N/A
- 52 Week Low
- XRTX $0.80
- ALLR $0.61
- 52 Week High
- XRTX $2.98
- ALLR $17.35
- Technical
- Relative Strength Index (RSI)
- XRTX 43.86
- ALLR 39.03
- Support Level
- XRTX $0.88
- ALLR $0.78
- Resistance Level
- XRTX $0.97
- ALLR $0.93
- Average True Range (ATR)
- XRTX 0.06
- ALLR 0.07
- MACD
- XRTX -0.01
- ALLR -0.02
- Stochastic Oscillator
- XRTX 18.85
- ALLR 18.72
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.